Centocor joins its parent company in blogosphere

Share this article:

Centocor launched itself into the blogosphere with the debut of its corporate blog at cnto411.com.

Melissa Katz, a Centoco spokeswoman, told MM&M the corporate blog aims to serve as a forum for discussion on issues relevant to the industry and not a platform for sounding off on Centocor products.

“I plan on posting to the blog as often as I can on issues that are relevant, hopefully a couple of times a week,” Katz said.

Michael Parks, VP of corporate comms and executive producer of Centocor's unbranded feature length film Innerstate, will serve in the role the blog's guest author.

“Around the time of Innerstate's debut about a year ago, we realized that we weren't paying enough attention to the blogosphere,” Katz said. “Since then we have been working with those bloggers to see how we can better communicate with them.”

Centocor joins its parent company Johnson & Johnson, which began corporate blogging with jnjbtw.com last summer.

Johnson & Johnson's blog, edited by spokesman Marc Monseau, has taken a similar tack as a forum for discussion of non-product specific, industry-related issues.

On the product blogging front, GlaxoSmithKline's Alli team keeps a blog on the OTC weight loss treatment (alliconnect.com).

Novartis briefly experimented with an oncology blog, melanomaperspectives.com, aimed at physicians and written by KOLs, toward the end of 2007, but quickly pulled it.

 

 

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.